Advanced

Metabolic Syndrome and Endometrial Carcinoma

Bjorge, Tone; Stocks, Tanja; Lukanova, Annekatrin; Tretli, Steinar; Selmer, Randi; Manjer, Jonas LU ; Rapp, Kilian; Ulmer, Hanno; Almquist, Martin LU and Concin, Hans, et al. (2010) In American Journal of Epidemiology 171(8). p.892-902
Abstract
The authors examined the association between the metabolic syndrome and risk of incident endometnal and fatal uterine corpus cancer within a large prospective cohort study Approximately 290,000 women from Austria, Norway, and Sweden were enrolled during 1974-2005, with measurements of height, weight, systolic and diastolic blood pressure, and circulating levels of glucose, total cholesterol, and tnglycendes Relative risks were estimated using Cox proportional hazards regression. The metabolic syndrome was assessed as a composite z score, as the standardized sum of z scores for body mass index, blood pressure, glucose, cholesterol, and tnglycendes. A total of 917 endonnetnal carcinomas and 129 fatal cancers were identified Increased risks... (More)
The authors examined the association between the metabolic syndrome and risk of incident endometnal and fatal uterine corpus cancer within a large prospective cohort study Approximately 290,000 women from Austria, Norway, and Sweden were enrolled during 1974-2005, with measurements of height, weight, systolic and diastolic blood pressure, and circulating levels of glucose, total cholesterol, and tnglycendes Relative risks were estimated using Cox proportional hazards regression. The metabolic syndrome was assessed as a composite z score, as the standardized sum of z scores for body mass index, blood pressure, glucose, cholesterol, and tnglycendes. A total of 917 endonnetnal carcinomas and 129 fatal cancers were identified Increased risks of incident endometnal carcinoma and fatal uterine corpus cancer were seen for the metabolic syndrome factors combined, as well as for individual factors (except for cholesterol) The relative risk of endometnal carcinoma for the metabolic syndrome was 1.37 (95% confidence interval 1 28, 1 46) per 1-unit increment of z score The positive associations between metabolic syndrome factors (both individually and combined) and endometrial carcinoma were confined to the heaviest women. The association between the metabolic syndrome and endometnal carcinoma risk seems to go beyond the risk conferred by obesity alone, particularly in women with a high body mass index (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
cohort studies, endometrial neoplasms, metabolic syndrome X
in
American Journal of Epidemiology
volume
171
issue
8
pages
892 - 902
publisher
Oxford University Press
external identifiers
  • wos:000277078300006
  • scopus:77950848588
ISSN
0002-9262
DOI
10.1093/aje/kwq006
language
English
LU publication?
yes
id
e6e13db9-4afb-4e4d-afb4-62a2f49753e1 (old id 1619566)
date added to LUP
2010-06-18 08:42:51
date last changed
2018-05-29 11:02:23
@article{e6e13db9-4afb-4e4d-afb4-62a2f49753e1,
  abstract     = {The authors examined the association between the metabolic syndrome and risk of incident endometnal and fatal uterine corpus cancer within a large prospective cohort study Approximately 290,000 women from Austria, Norway, and Sweden were enrolled during 1974-2005, with measurements of height, weight, systolic and diastolic blood pressure, and circulating levels of glucose, total cholesterol, and tnglycendes Relative risks were estimated using Cox proportional hazards regression. The metabolic syndrome was assessed as a composite z score, as the standardized sum of z scores for body mass index, blood pressure, glucose, cholesterol, and tnglycendes. A total of 917 endonnetnal carcinomas and 129 fatal cancers were identified Increased risks of incident endometnal carcinoma and fatal uterine corpus cancer were seen for the metabolic syndrome factors combined, as well as for individual factors (except for cholesterol) The relative risk of endometnal carcinoma for the metabolic syndrome was 1.37 (95% confidence interval 1 28, 1 46) per 1-unit increment of z score The positive associations between metabolic syndrome factors (both individually and combined) and endometrial carcinoma were confined to the heaviest women. The association between the metabolic syndrome and endometnal carcinoma risk seems to go beyond the risk conferred by obesity alone, particularly in women with a high body mass index},
  author       = {Bjorge, Tone and Stocks, Tanja and Lukanova, Annekatrin and Tretli, Steinar and Selmer, Randi and Manjer, Jonas and Rapp, Kilian and Ulmer, Hanno and Almquist, Martin and Concin, Hans and Hallmans, Goran and Jonsson, Hakan and Stattin, Par and Engeland, Anders},
  issn         = {0002-9262},
  keyword      = {cohort studies,endometrial neoplasms,metabolic syndrome X},
  language     = {eng},
  number       = {8},
  pages        = {892--902},
  publisher    = {Oxford University Press},
  series       = {American Journal of Epidemiology},
  title        = {Metabolic Syndrome and Endometrial Carcinoma},
  url          = {http://dx.doi.org/10.1093/aje/kwq006},
  volume       = {171},
  year         = {2010},
}